JSR Micro, Inc. Expands JSR Life Sciences Business with MBL International, Appoints New CEO

JSR Micro, Inc. announced today that it has expanded the JSR Life Sciences business division by becoming the majority shareholder of Boston area-based MBL International Corporation (MBLI). Tim Lowery, Sr. Vice President of Emerging Technologies at JSR Micro, Inc., has been appointed as the Chief Executive Officer of MBLI effective immediately. 

MBLI is a life sciences company focused on providing high quality, innovative, solutions-based products for life sciences research and clinical diagnostics. The company has more than 20 years of experience developing research products and technologies for immunology, cell biology and protein analysis as well as assays for disease biomarker analysis in immuno-oncology, cardiovascular disease, autoimmune disease and more. MBLI also provides diagnostic products for autoimmune disease, infectious disease and virology. MBLI integrates the operations of the Americas and European markets for the MBL group.

JSR Micro, Inc., as a US-based subsidiary of JSR Corporation, had been leading the business development of JSR Life Sciences in the North American market, and is now becoming the lead role for JSR’s global life sciences businesses. The acquisition of MBLI will let JSR Micro, Inc. and JSR Life Sciences reach into the diagnostics and research markets by further expanding its business and product portfolio, especially in North America and Europe. JSR Micro, Inc. plans to fully integrate its existing diagnostics and research products activities with those of MBLI and operate as a single unit.

Read the full press release